Both NAFLD-HCC and ALD-HCC showed lower levels of CXCL8 (IL-8) and CCL3, compared to their respective cirrhotic counterparts (Figure 3B). Here, CXCL8 is linked to metabolic dysfunction-associated steatotic liver disease.